Wunderlich Securities Downgrades Imperva (IMPV) to Hold
FREE Breaking News Alerts from StreetInsider.com!
StreetInsider.com Top Tickers, 10/21/2026
Go back to Wunderlich Securities Downgrades Imperva (IMPV) to Hold
August 8, 2016 7:19 AM EDT
Imperial Capital maintained an Outperform rating on Imperva (NYSE: IMPV), and cut the price target to $50.00 (from $55.00), following the company's 2Q earnings report. IMPV reported revenue of $57.9mn and adjusted net loss per share of $0.23. IMPV previously reported preliminary 2Q16 revenue of $57.5-58.0mn and adjusted... More
August 5, 2016 7:27 AM EDT
Needham & Company upgraded Imperva (NYSE: IMPV) from Hold to Buy with a price target of $64.00, as Qatalyst hired for a potential sale.
Analyst Scott Zeller commented, "Our IMPV downgrade post MarQ was based on our lack of confidence that IMPV could achieve... More
August 4, 2016 4:43 PM EDT
Imperva (NYSE: IMPV) announced that its Board of Directors has initiated a comprehensive review of strategic alternatives to enhance shareholder value. The Board has retained Qatalyst Partners as financial advisor and Fenwick & West as legal advisor to assist in the process.
Impervas Board is... More
August 4, 2016 4:41 PM EDT
Imperva (NYSE: IMPV) reported Q2 EPS of ($0.23), $0.06 worse than the analyst estimate of ($0.17). Revenue for the quarter came in at $57.9 million versus the consensus estimate of $59.11 million.
GUIDANCE:
Imperva sees FY2016 EPS of ($0.82)-($0.78). Imperva sees FY2016 revenue of $248.6-250.6... More
